Transgenic approaches for plant disease control: Status and prospects 2021

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Transgenic approaches for plant disease control : Status and prospects 2021. / Collinge, David B.; Sarrocco, Sabrina.

I: Plant Pathology, Bind 71, Nr. 1, 2022, s. 207-225.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Collinge, DB & Sarrocco, S 2022, 'Transgenic approaches for plant disease control: Status and prospects 2021', Plant Pathology, bind 71, nr. 1, s. 207-225. https://doi.org/10.1111/ppa.13443

APA

Collinge, D. B., & Sarrocco, S. (2022). Transgenic approaches for plant disease control: Status and prospects 2021. Plant Pathology, 71(1), 207-225. https://doi.org/10.1111/ppa.13443

Vancouver

Collinge DB, Sarrocco S. Transgenic approaches for plant disease control: Status and prospects 2021. Plant Pathology. 2022;71(1):207-225. https://doi.org/10.1111/ppa.13443

Author

Collinge, David B. ; Sarrocco, Sabrina. / Transgenic approaches for plant disease control : Status and prospects 2021. I: Plant Pathology. 2022 ; Bind 71, Nr. 1. s. 207-225.

Bibtex

@article{8376d221121a4381a0558ceb542b80b4,
title = "Transgenic approaches for plant disease control: Status and prospects 2021",
abstract = "Plant diseases represent a major constraint on agricultural production. Finding sustainable novel means for their control is an important challenge. The ever-increasing knowledge and understanding of plant-microbe interactions has led to several ingenious transgenic approaches to combat disease. The first transgenic disease-resistant plants expressed single or a few stacked genes encoding antimicrobial proteins. Whereas the first attempts were disappointing in the field, several examples from recent field studies are promising and some of these use ingenious designer approaches. Less progress has been made with antimicrobial metabolites where the challenges lie in obtaining biosynthetic genes and in coordinating their expression. The increased understanding of the processes regulating plant defence (plant immunity) and modes of action of pathogen effector proteins have also led to novel strategies for designing resistant plants. The most promising of these is host-induced gene silencing that targets specific pathogens, either the effectors or, preferably, essential housekeeping genes. With these approaches, and several maverick examples of {"}genes pulled out of a hat,{"} the technical effort in designing resistant plants is finally paying off. The prospects are good, biologically speaking, but can industry deliver? There is still an issue of public acceptance of genetic engineering of crop plants, especially in Europe; so whilst considerable strategic and practical progress has been made over the last decade, vanishingly few products have been adopted by agriculture. Some of these have been in use for over two decades. As yet, all are against viral diseases and not against diseases caused by microorganisms.",
keywords = "GMO, transgenic disease resistance, CONFERS STRONG RESISTANCE, BARLEY BAX INHIBITOR-1, PLUM-POX-VIRUS, ENHANCED RESISTANCE, MOSAIC-VIRUS, GENETIC-TRANSFORMATION, FUSARIUM-OXYSPORUM, ENGINEERING PLANTS, DEFENSE RESPONSES, CHITINASE GENE",
author = "Collinge, {David B.} and Sabrina Sarrocco",
note = "Special Issue: On the topic of Plant Health in a One Health context",
year = "2022",
doi = "10.1111/ppa.13443",
language = "English",
volume = "71",
pages = "207--225",
journal = "Plant Pathology",
issn = "0032-0862",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - Transgenic approaches for plant disease control

T2 - Status and prospects 2021

AU - Collinge, David B.

AU - Sarrocco, Sabrina

N1 - Special Issue: On the topic of Plant Health in a One Health context

PY - 2022

Y1 - 2022

N2 - Plant diseases represent a major constraint on agricultural production. Finding sustainable novel means for their control is an important challenge. The ever-increasing knowledge and understanding of plant-microbe interactions has led to several ingenious transgenic approaches to combat disease. The first transgenic disease-resistant plants expressed single or a few stacked genes encoding antimicrobial proteins. Whereas the first attempts were disappointing in the field, several examples from recent field studies are promising and some of these use ingenious designer approaches. Less progress has been made with antimicrobial metabolites where the challenges lie in obtaining biosynthetic genes and in coordinating their expression. The increased understanding of the processes regulating plant defence (plant immunity) and modes of action of pathogen effector proteins have also led to novel strategies for designing resistant plants. The most promising of these is host-induced gene silencing that targets specific pathogens, either the effectors or, preferably, essential housekeeping genes. With these approaches, and several maverick examples of "genes pulled out of a hat," the technical effort in designing resistant plants is finally paying off. The prospects are good, biologically speaking, but can industry deliver? There is still an issue of public acceptance of genetic engineering of crop plants, especially in Europe; so whilst considerable strategic and practical progress has been made over the last decade, vanishingly few products have been adopted by agriculture. Some of these have been in use for over two decades. As yet, all are against viral diseases and not against diseases caused by microorganisms.

AB - Plant diseases represent a major constraint on agricultural production. Finding sustainable novel means for their control is an important challenge. The ever-increasing knowledge and understanding of plant-microbe interactions has led to several ingenious transgenic approaches to combat disease. The first transgenic disease-resistant plants expressed single or a few stacked genes encoding antimicrobial proteins. Whereas the first attempts were disappointing in the field, several examples from recent field studies are promising and some of these use ingenious designer approaches. Less progress has been made with antimicrobial metabolites where the challenges lie in obtaining biosynthetic genes and in coordinating their expression. The increased understanding of the processes regulating plant defence (plant immunity) and modes of action of pathogen effector proteins have also led to novel strategies for designing resistant plants. The most promising of these is host-induced gene silencing that targets specific pathogens, either the effectors or, preferably, essential housekeeping genes. With these approaches, and several maverick examples of "genes pulled out of a hat," the technical effort in designing resistant plants is finally paying off. The prospects are good, biologically speaking, but can industry deliver? There is still an issue of public acceptance of genetic engineering of crop plants, especially in Europe; so whilst considerable strategic and practical progress has been made over the last decade, vanishingly few products have been adopted by agriculture. Some of these have been in use for over two decades. As yet, all are against viral diseases and not against diseases caused by microorganisms.

KW - GMO

KW - transgenic disease resistance

KW - CONFERS STRONG RESISTANCE

KW - BARLEY BAX INHIBITOR-1

KW - PLUM-POX-VIRUS

KW - ENHANCED RESISTANCE

KW - MOSAIC-VIRUS

KW - GENETIC-TRANSFORMATION

KW - FUSARIUM-OXYSPORUM

KW - ENGINEERING PLANTS

KW - DEFENSE RESPONSES

KW - CHITINASE GENE

U2 - 10.1111/ppa.13443

DO - 10.1111/ppa.13443

M3 - Review

VL - 71

SP - 207

EP - 225

JO - Plant Pathology

JF - Plant Pathology

SN - 0032-0862

IS - 1

ER -

ID: 276164632